HCP, or Patient with a referral code?

Irritable Bowel Syndrome (IBS): An evidence-based guide to treatment

BioCeuticals IBS treatment protocol Header.png

This treatment protocol provides an evidence-based guide to treatment for IBS, which affects approximately 15% of the global population.

  • IBS is a common functional gastrointestinal disorder.
  • In IBS, communications are disrupted between the brain and gastrointestinal tract, known as the gut-brain axis.
  • It is characterised by abdominal pain, bloating, and altered bowel habits, which may include diarrhoea, constipation, or a mix of both.
  • The condition lacks a clear organic cause but is often associated with stress, microbiome imbalances, and food sensitivities.